Daily Bulletin

Men's Weekly

.

Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors

TOULOUSE, France, Nov. 9, 2020 /PRNewswire/ -- Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pierre Fabre Medical Care R&D teams. The study...

Read more: Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody...

More Articles ...

  1. OrbusNeich® Medical and P+F Products & Features® announce new partnership-PR Newswire APAC
  2. The world's largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start
  3. Global Beauty & Wellness Awards announces Best Cosmetics and Hotels in the World 2020-PR Newswire APAC
  4. Centennial Property Group Announces Offering of AUD$100Million Senior Secured Loan Note Program-PR Newswire APAC
  5. Amcor reports strong first quarter results and raises outlook for fiscal 2021-PR Newswire APAC
  6. Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy
  7. New football simulator Football for Friendship World to be released on World Football Day
  8. FP Markets recognised as 'Best FX Broker Australia' for 2020
  9. Cellarity signs up with Excelra for GOSTAR database to enrich its drug discovery platform-PR Newswire APAC
  10. Cloud4C and SNP Ink Global Partnership Agreement-PR Newswire APAC

Business News

How HZad Education Supports International Students Preparing for CELPIP in Australia

As Australia officially accepts CELPIP (Canadian English Language Proficiency Index Program) for visa applications, international students face new opportunities alongside unprecedented preparation ch...

Daily Bulletin - avatar Daily Bulletin

Online Site Inductions for Busy HR Teams

Induct For Work, the Australian platform for frontline onboarding and compliance, has launched Compliance Hub, a fully integrated, real-time workflow designed specifically for the fast-paced, highly m...

Daily Bulletin - avatar Daily Bulletin

Reporting Tools in Cybersecurity and Penetration Testing

Reporting is a critical part of every penetration testing engagement. After vulnerabilities have been identified and verified, the findings must be documented clearly and systematically to inform deve...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals